Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TJ0113 in Age-Related Hearing Loss
NCT07012746Not yet recruiting
- Start
- Jun 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in age-related hearing loss comparing TJ0113 group with Placebo group (2 arms). Primary endpoint: Safety of TJ0113 capsule at 25 weeks. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
TJ0113
03
Conditions
age-related hearing loss
Beyond the preview
Go deeper on NCT07012746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07012746.